PROCESSA PHARMACEUTICALS INC (PCSA) Stock Analyst Ratings
NASDAQ:PCSA - Nasdaq - US74275C3043 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to PCSA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 1054.72% above the current price.
PCSA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PCSA.
In the previous month the buy percentage consensus was at a similar level.
PCSA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-25 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-06 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-11-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-04-04 | Benchmark | Maintains | Speculative Buy |
| 2023-04-03 | Oppenheimer | Maintains | Outperform |
| 2023-01-12 | Maxim Group | Maintains | Buy |
| 2022-04-19 | Maxim Group | Initiate | Buy |
| 2021-08-03 | Oppenheimer | Initiate | Outperform |
| 2021-08-02 | Oppenheimer | Initiate | Outperform |